Cyclerion Therapeutics Inc (NASDAQ:CYCN)
| 4.41 Delayed Data As of Jun 08 |  -0.0733 / -1.63%Today’s Change | 3.64 Today|||52-Week Range 25.00 | -66.40% Year-to-Date |
Latest CYCN News | Press Releases
No recent news for Cyclerion Therapeutics Inc.
Today’s Trading
| Previous close | 4.48 |
| Today’s open | 4.27 |
| Day’s range | 4.27 - 4.41 |
| Volume | 43 |
| Average volume (3 months) | 26,389 |
| Market cap | $9.5M |
Data as of 3:55pm ET, 06/08/2023
Growth & Valuation
| Earnings growth (last year) | +23.15% |
| Earnings growth (this year) | -24.75% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -58.78% |
| P/E ratio | NM |
| Price/Sales | 17.55 |
| Price/Book | 0.91 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARDSAridis Pharmaceutica... | +0.02 | +6.15% |
| PULMPulmatrix Inc | -0.02 | -0.54% |
| --Obseva SA | 0.00 | 0.00% |
| ---- |
Data as of 3:59pm ET, 06/08/2023
Financials
| Last reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$6.20 |
| Annual revenue (last year) | $1.6M |
| Annual profit (last year) | -$44.1M |
| Net profit margin | -2,712.49% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
